samedan logo
 
 
 
spacer
home > ebr > summer 2003 > visualisation in drug discovery: the way of the future
PUBLICATIONS
European Biopharmaceutical Review

Visualisation in Drug Discovery: The Way of the Future

A geographically dispersed drug discovery team whose members are based in Oslo, Toronto and London analyse unimaginably large molecular model data together, at the same time, by visualising virtual molecules in 3D whilst in different offices. As they work, the team is able to make changes to the 3D data in real-time helping them reach a collaborative decision quickly. They are working under enormous pressure to develop an urgently needed new drug and the visualisation technology allows them to reach a marketable cure in record time. World experts can work together easily even though they are based hundreds of thousands of miles apart. Welcome to drug discovery supported by visual area networking.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dan Stevens, Marketing Manager, Life and Chemical Sciences at SGI

Dan Stevens PhD is Market Manager for Life Sciences at SGI. His responsibilities include developing strategies for SGI's high-performance computing solutions in the chemistry and biotechnology market areas. Dan undertook a clinical specialty in the field of Periodontics and has a PhD in Immunology from the University of North Carolina at Chapel Hill.

Before joining SGI, Dan worked at Procter and Gamble as a Senior Scientist in the department of Regulatory and Clinical Development, where he was responsible for designing clinical trials to demonstrate drug efficacy.

spacer
Dan Stevens
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced today an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments.
More info >>

White Papers

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek Ltd

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement